Related Experiment Video
Updated: Jun 6, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Intensity-modulated radiation therapy for breast: is it for everyone?
1Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. mccormib@mskcc.org
Seminars in Radiation Oncology
|December 8, 2010
Summary
Intensity-modulated radiation therapy (IMRT) improves breast cancer treatment by enhancing dose homogeneity, significantly reducing side effects like fibrosis. Research continues to explore its benefits for chest wall and lymphatic treatments.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Intensity-modulated radiation therapy (IMRT) initially aimed to improve dose conformity for cancer treatment.
- For breast cancer, IMRT's primary goal shifted to enhancing dose homogeneity within the breast tissue.
Purpose of the Study:
- To evaluate the effectiveness of IMRT in improving dose homogeneity for breast cancer treatment.
- To compare IMRT outcomes against standard radiation planning methods.
Main Methods:
- Analysis of two prospective randomized trials comparing IMRT with standard breast cancer treatment planning.
- Assessment of acute side effects and late fibrosis in patients treated with IMRT.
Main Results:
- IMRT significantly decreased both acute side effects and late fibrosis compared to standard planning.
- Dose homogeneity achieved with IMRT was directly correlated with reduced side effects.
- While IMRT can improve conformality, its benefit for breast-only treatment was not consistently perceived as superior due to anatomical considerations.
Conclusions:
- IMRT offers significant advantages in reducing toxicity for breast cancer patients by improving dose homogeneity.
- Ongoing research investigates IMRT's potential for treating the breast, chest wall, and regional lymphatics.
- IMRT demonstrates benefits in specific anatomical challenges like pectus excavatum.
